Acetaminophen News and Research RSS Feed - Acetaminophen News and Research

The pain-reliever acetaminophen (also known as paracetomol) is one of the best-selling over-the-counter medications, used by more than 200 million Americans a year. It is sold under many brand names, including Tylenol, and is an ingredient in nearly 200 medications, both over-the-counter (such as Excedrin, Midol, NyQuil, and Sudafed) and prescription (such as Vicodin).
Anika Therapeutics reports first commercial sale of Monovisc in the U.S.

Anika Therapeutics reports first commercial sale of Monovisc in the U.S.

Anika Therapeutics, Inc., a leader in products for tissue protection, healing and repair, based on hyaluronic acid ("HA") technology, today announced the first U.S. commercial sale of Monovisc by its commercial partner, DePuy Synthes Mitek Sports Medicine, a leading orthopedic sports medicine company. [More]
New approach to breast reconstruction surgery decreases use of postoperative opioid painkiller

New approach to breast reconstruction surgery decreases use of postoperative opioid painkiller

A new approach to breast reconstruction surgery aimed at helping patients' bodies get back to normal more quickly cut their postoperative opioid painkiller use in half and meant a day less in the hospital on average, a Mayo Clinic study found. [More]
ASN to conduct Scientific Sessions and Annual Meeting at Experimental Biology in San Diego

ASN to conduct Scientific Sessions and Annual Meeting at Experimental Biology in San Diego

The American Society for Nutrition (ASN) will hold its 2014 Scientific Sessions and Annual Meeting at Experimental Biology (EB), from April 26-30, 2014, in San Diego. EB 2014 brings together the leading researchers from dozens of life-science disciplines. [More]
Study raises concerns about use of acetaminophen during pregnancy

Study raises concerns about use of acetaminophen during pregnancy

Acetaminophen, found in over-the-counter products such as Excedrin and Tylenol, provides many people with relief from headaches and sore muscles. When used appropriately, it is considered mostly harmless. Over recent decades, the drug, which has been marketed since the 1950s, has become the medication most commonly used by pregnant women for fevers and pain. [More]
Anika Therapeutics receives marketing approval from FDA for MONOVISC injection

Anika Therapeutics receives marketing approval from FDA for MONOVISC injection

Anika Therapeutics, Inc. today announced it has received marketing approval for MONOVISC from the U.S. Food and Drug Administration. MONOVISC is a single injection supplement to synovial fluid of the osteoarthritic joint, used to treat pain and improve joint mobility in patients suffering from osteoarthritis (OA) of the knee. [More]
Children of women who used acetaminophen during pregnancy appear to be at higher risk for ADHD

Children of women who used acetaminophen during pregnancy appear to be at higher risk for ADHD

Children of women who used the pain reliever acetaminophen (paracetamol) during pregnancy appear to be at higher risk for attention-deficit/hyperactivity disorder (ADHD)-like behavioral problems and hyperkinetic disorders. [More]

Mallinckrodt's subsidiary to acquire all outstanding shares of Cadence Pharmaceuticals

Mallinckrodt plc, a leading global specialty pharmaceuticals company, and Cadence Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt plc will commence a tender offer to acquire all outstanding shares of Cadence Pharmaceuticals, Inc. for $14.00 per share in cash or approximately $1.3 billion on a fully diluted basis, which represents a 32% premium to the trailing 30-trading-day volume weighted average price (VWAP) of $10.62 per share for Cadence Pharmaceuticals, Inc. [More]
Study: Women who take aspirin daily may reduce risk of ovarian cancer by 20%

Study: Women who take aspirin daily may reduce risk of ovarian cancer by 20%

Women who take aspirin daily may reduce their risk of ovarian cancer by 20 percent, according to a study by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health. However, further research is needed before clinical recommendations can be made. [More]
Researchers identify key step to prevent liver failure resulting from painkiller overdose

Researchers identify key step to prevent liver failure resulting from painkiller overdose

University of Adelaide researchers have identified a key step for the future prevention of liver failure resulting from taking too much of the everyday painkiller paracetamol (also known as acetaminophen). [More]
Use of fever-reducing drugs may lead to tens of thousands more influenza cases

Use of fever-reducing drugs may lead to tens of thousands more influenza cases

Contrary to popular belief, fever-reducing medication may inadvertently cause more harm than good. New research from McMaster University has discovered that the widespread use of medications that contain fever-reducing drugs may lead to tens of thousands more influenza cases, and more than a thousand deaths attributable to influenza, each year across North America. [More]
Research: SLPI protein produced by body in response to injury plays vital role in patients with ALF

Research: SLPI protein produced by body in response to injury plays vital role in patients with ALF

Findings published in the American Association for the Study of Liver Diseases journal, Hepatology, indicate that infection, the commonest cause of mortality in patients with acute liver failure, may be decreased by inhibiting the activity of a protein found in saliva called SLPI. [More]
Research report on global pain management devices market

Research report on global pain management devices market

Research and Markets has announced the addition of the "Global Pain Management Devices Market Report 2013-2018 " report to their offering. [More]
College students not only bring dirty socks but also mononucleosis to home

College students not only bring dirty socks but also mononucleosis to home

One of the hallmarks of heading home for winter break is the enormous amounts of laundry college students bring as a welcome home present for Mom and Dad. But the dirty socks might not be the only unwelcome guest they transport home. They might also bring mononucleosis, better known as mono. [More]
Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

Novartis will present updates on its broad cancer portfolio with more than 240 abstracts at the upcoming American Society of Hematology (ASH) annual meeting and CTRC-AACR San Antonio Breast Cancer Symposium (SABCS). [More]

Scientists investigate factors that influence choice of abused drugs

Prescription opioid abuse has reached epidemic levels in the past 15 years. Scientists investigating why people favor one drug over another have found that oxycodone and hydrocodone are the drugs of choice for 75% of opioid-dependent individuals. [More]
Study suggests potential new treatment for seizures

Study suggests potential new treatment for seizures

A study out today in the journal Nature Medicine suggests a potential new treatment for the seizures that often plague children with genetic metabolic disorders and individuals undergoing liver failure. The discovery hinges on a new understanding of the complex molecular chain reaction that occurs when the brain is exposed to too much ammonia. [More]
Cumberland Pharmaceuticals net revenue decreases from $12.5 to $6.5 million

Cumberland Pharmaceuticals net revenue decreases from $12.5 to $6.5 million

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today announced third quarter 2013 financial results. [More]

Even light consumption of alcohol with acetaminophen can increase risk of kidney dysfunction

New research finds that the combination of acetaminophen paired with alcohol — even if consumed moderately or lightly — can increase the risk of kidney dysfunction, according to new research released today at the American Public Health Association's 141st Annual Meeting in Boston. [More]
Long-term use of paracetamol during pregnancy increases risk of adverse effects on child development

Long-term use of paracetamol during pregnancy increases risk of adverse effects on child development

Paracetamol (acetaminophen) is the most commonly used medicine in pregnancy, yet there are very few studies that have investigated the possible long-term consequences for the child. [More]

Study investigates effect of paracetamol during pregnancy on child development

Paracetamol (acetaminophen) is the most commonly used medicine in pregnancy, yet there are very few studies that have investigated the possible long-term consequences for the child. A new study from the Norwegian Institute of Public Health suggests that long-term use of paracetamol during pregnancy may increase the risk of adverse effects on child development. [More]